Company Filings — 20 August 2026

1,807 regulatory filings were published by NSE- and BSE-listed companies on 20 August 2026 — showing page 19 of 19.

  1. Allots Warrants to Promoters, Raises ₹150 Cr Upfront

    Krishna Institute of Medical Sciences Limited · KIMS · NSE ·

    Allotted 77,02,182 convertible warrants to its Promoter and Promoter Group on a preferential basis. Raised ~₹150 crores as 25% upfront payment. The total issue size is ~₹600 crores upon full conversion at an issue price of ₹779 per warrant. Each warrant is convertible into one eq…

  2. KIMS Raises ₹150 Crore via Warrant Allotment to Promoters

    Krishna Institute of Medical Sciences Limited · KIMS · NSE ·

    Allotted 77,02,182 convertible warrants to the Promoter and Promoter Group on a preferential basis at an issue price of ₹779 per warrant. Received an immediate cash inflow of ~₹150 crore, representing 25% of the total issue price. A further ~₹450 crore will be infused upon conver…

  3. To Raise ₹600 Crore via Preferential Warrant Issue

    Krishna Institute of Medical Sciences Ltd · 543308 · BSE ·

    <ul> <li>The company has allotted 77,02,182 warrants on a preferential basis to its Promoter and Promoter Group.</li> <li>The total capital to be raised from this issue is approximately ₹600 crore at an issue price of ₹779 per warrant.</li> <li>An upfront payment of ~₹150 crore (…

  4. Promoters to Infuse ₹600 Crore via Preferential Warrant Allotment

    Krishna Institute of Medical Sciences Ltd · 543308 · BSE ·

    The company has allotted 77,02,182 convertible warrants to its Promoters and Promoter Group at an issue price of ₹779 per warrant. The total issue size is approximately ₹600 crore, with an immediate capital infusion of ~₹150 crore (25% upfront payment) already received. Each warr…

  5. Annual Report, Dividend & ₹69 Cr Fundraising for UAE Expansion

    Suraj Products Ltd · 518075 · BSE ·

    **Financials:** FY26 Standalone PAT fell 12.1% to ₹188.48 Cr due to lower price realisation. The company reported its first consolidated PAT at ₹187.17 Cr. **Dividend:** Recommended a final dividend of **₹2.25 per equity share** for the financial year 2025-26. **Fundraising:** Pr…

  6. Annual Report Highlights: Dividend, ₹69 Cr Fundraise & UAE Project

    Suraj Products Ltd · 518075 · BSE ·

    **FY26 Performance:** Standalone Profit After Tax (PAT) declined by 12.1% to ₹188.5 Cr due to lower price realizations. Consolidated PAT for the year stood at ₹187.2 Cr. **Dividend Declared:** The board has recommended a final dividend of **₹2.25 per equity share** for the financ…

  7. FY26 Results: Declares Dividend & Plans ₹69 Cr Fundraise for UAE Expansion

    Suraj Products Ltd · 518075 · BSE ·

    **Financial Performance (Standalone, YoY):** Profit After Tax (PAT) for FY26 declined by 12.1% to ₹1,884.79 lakh, with EPS at ₹16.53. The company attributes the lower profitability to a fall in per-tonne price realisation. **Dividend Declared:** The Board has recommended a final…